H.C. Wainwright initiated coverage on Korro Bio Inc (NASDAQ: KRRO), a biotech company developing genetic medicines focused on editing ribonucleic acid (RNA) to treat various diseases.
https://www.marijuanamoment.net/germany-delays-final-vote-on-marijuana-legalization-bill-until-next-year/A final vote on a bill to legalize marijuana in Germany that was initially planned for this week has been called
CEL-SCI Corporation (AMEX: CVM) announced that the British National Institute for Health and Care Excellence (NICE) has selected Multikine (Leukocyte Interleukin, Injection) to be evaluated as the potential new standard of care for squamous cell carcinoma of the head and neck
A dual JAK3/TEC inhibitor, LITFULO™ (ritlecitinib) is approved for adults and adolescents over 12 years of age for treatment of severe alopecia areata.KIRKLAND, QC, Dec. 4, 2023 /CNW/ - Today, Pfizer Canada
AirStrip visualization is currently deployed across more than 600 healthcare systems in the U.S.Joint commercialization agreement provides expansion of AirStrip Cardiology and Patient Monitoring solutions exclusively
Valneva SE (NASDAQ: VALN) reported antibody persistence data 24 months after vaccination with a single dose of its chikungunya vaccine IXCHIQ, further supporting the anticipated long-term durability of the immune response and in line with positive twelve-month persistence data the company reported
Weight Loss by Hims & Hers is designed to help people achieve and maintain their weight-loss goals with personalized and affordable clinical programs that combine medication management, digital tracking tools and
Alterity Therapeutics Inc (NASDAQ: ATHE) shares are trading higher after the company announced that ATHE434 new data in a Parkinson's disease primate model were presented at the Future of Parkinson's